Manganese transport in mammals by zinc transporter family proteins, ZNT and ZIP.


Journal

Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 23 07 2021
revised: 07 10 2021
accepted: 07 10 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 11 2 2022
Statut: ppublish

Résumé

Manganese (Mn) is an essential trace element required for various biological processes. However, excess Mn causes serious side effects in humans, including parkinsonism. Thus, elucidation of Mn homeostasis at the systemic, cellular, and molecular levels is important. Many metal transporters and channels can be involved in the transport and homeostasis of Mn, and an increasing body of evidence shows that several zinc (Zn) transporters belonging to the ZIP and ZNT families, specifically, ZNT10, ZIP8, and ZIP14, play pivotal roles in Mn metabolism. Mutations in the genes encoding these transporter proteins are associated with congenital disorders related to dysregulated Mn homeostasis in humans. Moreover, single nucleotide polymorphisms of ZIP8 are associated with multiple clinical phenotypes. In this review, we discuss the recent literature on the structural and biochemical features of ZNT10, ZIP8, and ZIP14, including transport mechanisms, regulation of expression, and pathophysiological functions. Because a disturbance in Mn homeostasis is closely associated with a variety of phenotypes and risk of human diseases, these transporters constitute a significant target for drug development. An understanding of the roles of these key transporters in Mn metabolism should provide new insights into pharmacological applications of their inhibitors and enhancers in human diseases.

Identifiants

pubmed: 34924116
pii: S1347-8613(21)00106-7
doi: 10.1016/j.jphs.2021.10.011
pii:
doi:

Substances chimiques

Cation Transport Proteins 0
SLC30A10 protein, human 0
SLC39A14 protein, human 0
SLC39A8 protein, human 0
Manganese 42Z2K6ZL8P

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-133

Informations de copyright

Copyright © 2021 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Both authors declare no competing financial and non-financial interests.

Auteurs

Hitomi Fujishiro (H)

Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan. Electronic address: donai-do@ph.bunri-u.ac.jp.

Taiho Kambe (T)

Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, 606-8502, Japan. Electronic address: kambe.taiho.7z@kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH